Data protection Impressum

Medtech

Top Stories Western Switzerland

Business environment

Top Stories from Western Switzerland (October 2025)

29 October 2025

Neurotechnology company ONWARD Medical extends its cash runway through 2026 and prepares to expand commercialization and clinical development of its ARC Therapy systems.

ONWARD Medical raises over EUR 50 million to advance spinal cord therapies

27 October 2025

Vaud-based FemTech company Aspivix begins commercial rollout in Southern California and New York following strong clinical validation and growing U.S. demand.

Aspivix launches its breakthrough Carevix device in the United States

21 October 2025

Geneva-based medtech company Spineart has secured a CHF 25 million investment from long-standing shareholders Gimv and EGS Beteiligungen (EGSB) to fuel its next phase of growth and global expansion.

Spineart raises CHF 25 million to accelerate global expansion and innovation

6 October 2025

Geneva-based Multiwave Technologies has secured CHF 3.6 million to accelerate regulatory approval of its portable MRI device and establish a new assembly facility in the United States.

Multiwave raises CHF 3.6 million and opens US operations in Boston

1 October 2025

Switzerland Innovation has launched an interactive map to simplify access to its network of innovation parks, offering international companies and partners a clearer entry point into Switzerland’s diverse R&D landscape.

Business environment

Switzerland Innovation unveils new map to strengthen international visibility of its ecosystem

29 September 2025

Bern-based medtech Rhovica Neuroimaging has secured CHF 2.3 million to accelerate development of its SoNav system for safer emergency neurosurgery.

Rhovica raises CHF 2.3 million to advance bedside neurosurgery navigation

2 September 2025

Neuchâtel, renowned globally for its watchmaking heritage, has evolved into a dynamic hub of cutting-edge innovation. Today, the canton leverages its tradition of precision craftsmanship to excel in fields as diverse as blockchain, quantum technology, renewable energy, life sciences, and advanced manufacturing. The canton of Neuchâtel’s transformation highlights its unique ability to merge historical excellence with visionary innovation, positioning itself as a leading force within Switzerland’s economic landscape.

Neuchâtel, a legacy of precision driving tomorrow’s innovation

Vaud-based medtech Comphya strengthens its clinical pipeline with fresh capital and prepares for pivotal trials in the United States.

Comphya raises CHF 7.5 million for its neurostimulation therapy to treat erectile dysfunction

14 July 2025

Biopôle adds 18 new private labs for life sciences scale-ups in Lausanne, offering flexible, plug-and-play infrastructure in the new Trypto building.

Biopôle expands with 18 new private laboratories for life sciences scale-ups

2 July 2025

1 2 3 4 5 … 17